The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection

AIDS

Volumn 8, Issue 5, 1994, Pages 651-654

  Nelson, Mark R ^a   Fisher, Martin ^a   Cartledge, Jonathan ^a   Rogers, Tom ^a   Gazzard, Brian G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Cryptococcus; Fluconazole; Itraconazole; Ketoconazole; Meningitis

Indexed keywords

AMPHOTERICIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; DRUG EFFICACY; FUNGAL MENINGITIS; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SEROLOGY; UNITED KINGDOM;

EID: 0028258525     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199405000-00011     Document Type: Article

References (21)

1. Levy RM, Bredeson DE, Rosenblum ML: Neurological manifestations of the acquired immunodeficiency virus (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985, 62:475-495.
2. Dismukes WE: Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988, 157:624-628.
3. Chuck SL, Sande MA: Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Eng J Med 1989, 321:794-799.
4. Nelson MR, Bower M, Smith D, Reed C, Shanson D, Gazzard B: The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus. J Infect 1990, 21:175-181.
5. Bennett JE, Dismukes WE, Duma RJ, et al.: A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Eng J Med 1979, 301:126-131.
6. Dismukes WE, Cloud G, Gallis HA et al.: Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Eng J Med 1987, 317:334-341.
7. Kovacs JA, Kovacs AA, Polis M et al.: Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:533-538.
8. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ: Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986, 104:234-240.
9. Sugar AM, Stern JJ, Dupont B: Overview: treatment of cryptococcal meningitis. Rev Infect Dis 1990, 12 (suppl 3):S338-S348.
10. Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N: Spectrum of Cryptococcus neoformans infection in 68 patients infected with acquired immunodeficiency virus. Rev Infect Dis 1990, 12:768-777.
11. Saag MS, Powderly WG, Cloud GA, et al: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1993, 326:83-89.
12. Viviani MA, Tortorano AM, Langer M, et al.: Experience with itraconazole in cryptococcosis and aspergillosis. J Infect 1989, 18:151-165.
13. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA: Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989, 149:2301-2308.
14. de Gans J, Portegies P, Tiessens G, et al.: Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992, 6:185-190.
15. Powderly WG, Saag MS, Cloud GA: A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992, 326:793-798.
16. Nightingale SD, Cal SX, Peterson DM, et al.: Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1992, 6:191-194.
17. Sugar AM, Saunders C: Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with the acquired immunodeficiency syndrome. Am J Med 1988, 85:481-489.
18. Bozette SA, Larsen RA, Chiu J et al.: A placebo controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324:580-584.
19. Larsen RA: Azoles and AIDS. J Infect Dis 1990, 162:727-730.
20. Smith D, Vandevelde V, Woestenborghs R, Gazzard BG: The pharmacokinetics of oral itraconazole in AIDS patient. J Pharmacy Pharmacol 1992, 44:618-619.
21. Prentice AG, Warnock DW, Johnson San, Oliver DA: Multiple-dose pharmacokinetics of a new cyclodextrin solution formulation of itraconazole in patients under-going remission induction chemotherapy for acute myeloid leukaemia. International Congress of Antimicrobial Agents and Chemotherapy. Anaheim, October 1992 [abstract 744].